CIK: 1114914 - Address: C/o Vistagen Therapeutics, Inc., 343 Allerton Avenue, South San Francisco, CA 94080
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1117-0-2-9-29-36-34-18
S%wins717182829410083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/28/08 16:06
5/23/08
SCRXSciele Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSaxe Jon SGADS.d-7921.080-4-1719D
11/2/06 16:17
10/31/06
SCRXSciele Pharma, Inc.DEHealthDrugPharmaceutical PreparationsSaxe Jon SGADS.d-16421.830-8-2919D
4/20/06 17:51
4/18/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-15030.0133-5-752-1-5-36-41-32-19
4/12/06 17:00
4/10/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-15330.5833-5-43701-31-41-32-19
4/5/06 16:31
4/3/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-32832.7833-10-4612-3-9-34-43-42-33
3/31/06 17:56
3/29/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-16032.0033-5-1922-1-4-14-45-41-34
3/29/06 17:00
3/27/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-15631.2533-5-162700-11-48-42-33
3/22/06 16:51
3/20/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SCADS-32232.2433-10-2432-1-1-7-46-42-38
3/15/06 15:22
3/13/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-31731.7233-10-194200-6-44-38-40
3/10/06 18:14
3/8/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-16132.1233-5-95210-3-40-39-39
3/8/06 17:54
3/6/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15731.3733-5-857-1-3-1-44-42-45
3/7/06 17:26
3/3/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-16032.0033-5-762635-37-35-38
3/1/06 17:13
2/27/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15430.7133-5-7670-32-38-40-41
2/28/06 16:48
2/24/06
PDLIPdl Biopharma, Inc.DEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15030.0033-5-772111-36-42-40
1/11/06 17:52
1/9/06
PDLIProtein Design Labs Inc/deDEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-18430.6933-6-777-5-6-4-2-39-29
1/9/06 18:58
1/5/06
PDLIProtein Design Labs Inc/deDEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15030.0033-5-6831-10-9-2-42-35
1/6/06 18:06
1/4/06
PDLIProtein Design Labs Inc/deDEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15030.0332-5-5882-7-53-40-34
12/28/05 11:59
12/23/05
PDLIProtein Design Labs Inc/deDEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-30030.0031-10-1093D62404551450-203-112-41-30
10/20/05 18:53
10/4/05
PDLIProtein Design Labs Inc/deDEHealthBioPrdBiological Products, (No DiagSaxe Jon SX1DS-15130.2733-5-5103D99485920-7-2-3-105-1410-23

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact